1. Home/
  2. Compounds/
  3. SNX-2112:bortezomib (250:1 mol/mol)

SNX-2112:bortezomib (250:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2SNX-2112:bortezomib (250:1 mol/mol)
PharmacoGx SNX-2112:bortezomib (250:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to SNX-2112:bortezomib (250:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA DAZAP1 CTRPv2 pan-cancer AAC 0.17 1e-05
mRNA PRPF38A CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA SAFB CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA SH3BP1 CTRPv2 pan-cancer AAC 0.18 2e-06
mRNA SRSF7 CTRPv2 pan-cancer AAC 0.18 1e-06
mRNA ELAVL1 CTRPv2 pan-cancer AAC 0.18 6e-07
mRNA KHDRBS1 CTRPv2 pan-cancer AAC 0.18 2e-07
mRNA EXOSC9 CTRPv2 pan-cancer AAC 0.18 3e-07
mRNA SRSF3 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA RFXAP CTRPv2 pan-cancer AAC 0.18 1e-06
Download CSV